The trajectory of nutritional risk changes in patients with cervical cancer and its relationship with disease perception

Zhao Lingyu, Xie Bin, Deng Xuanjing, Wang Yanru, Zeng Youzhen

Electronic Journal of Metabolism and Nutrition of Cancer ›› 2026, Vol. 13 ›› Issue (4) : 519-525.

PDF(1195 KB)
PDF(1195 KB)
Electronic Journal of Metabolism and Nutrition of Cancer ›› 2026, Vol. 13 ›› Issue (4) : 519-525. DOI: 10.16689/j.cnki.cn11-9349/r.2026.04.010
Original Articles

The trajectory of nutritional risk changes in patients with cervical cancer and its relationship with disease perception

  • Zhao Lingyu, Xie Bin, Deng Xuanjing, Wang Yanru, Zeng Youzhen
Author information +
History +

Abstract

Objective To analyze the developmental trajectory of nutritional risk and disease perception among postoperative patients with cervical cancer, and to explore the predictive relationship between these two factors, thereby providing a theoretical basis for reducing disease perception and alleviating symptoms in patients with cervical cancer. Method A total of 132 patients diagnosed with cervical cancer were selected as research subjects using convenient sampling. Their nutritional risk and disease perception were tracked and investigated at three distinct time points: T1 (immediately following surgery), T2 (one month post-surgery), and T3 (two months post-surgery). Result A total of 118 valid questionnaires were retrieved in this study, (yielding a recovery rate of 89.39%. The cross-lag model indicates that at the initial stage, nutritional risk and disease perception can positively predict each other (β=0.423, P < 0.001). Specifically, nutritional risk significantly and positively predicted illness perception at the subsequent time point (T1→T2: β=0.440, P=0.012; T2→T3: β=0.430, P=0.004). Similarly, the average disease perception level significantly and positively predicts the nutritional risk level at the next time point (T1→T2: β=0.378, P=0.007; T2→T3: β=0.392, P=0.003). The latent variable growth model reveals that the initial level of nutritional risk positively predicts the initial level of disease perception (β=0.336, P=0.007) and can also positively predict the rate of development of disease perception (β=0.430, P=0.008). Furthermore, the rate of development of nutritional risk can positively predict the rate of development of disease perception (β=0.469, P < 0.001).Conclusion Medical staff should concentrate on monitoring the nutritional status and changes in disease perception among patients within two months following cervical cancer surgery. Early nutritional intervention, including personalized dietary support and enteral nutrition supplementation, can not only mitigate the body's nutritional risk but also indirectly alleviate symptoms and disease perception by reducing the rate of nutritional decline. Consequently, this can improve patient prognosis and enhance their quality of life.

Key words

Cervical cancer / Postoperative / Nutritional risk / Disease perception / Trajectory / Correlation / Latent variable growth model / Cross-lagged model

Cite this article

Download Citations
Zhao Lingyu, Xie Bin, Deng Xuanjing, Wang Yanru, Zeng Youzhen. The trajectory of nutritional risk changes in patients with cervical cancer and its relationship with disease perception[J]. Electronic Journal of Metabolism and Nutrition of Cancer. 2026, 13(4): 519-525 https://doi.org/10.16689/j.cnki.cn11-9349/r.2026.04.010

References

[1] Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2024,74(3):229-263.
[2] Ji L, Chen M, Yao L. Strategies to eliminate cervical cancer in China[J]. Front Oncol, 2023,13:1105468.
[3] Wu S, Jiao J, Yue X, et al. Cervical cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with England and India based on the global burden of disease study 2019[J]. Front Public Health, 2024,12:1358433.
[4] Wu X, Sun Y, Yang H, et al. Cadonilimab plus platinum-based chemotherapy with or without bevacizumab as first-line treatment for persistent, recurrent, or metastatic cervical cancer (COMPASSION-16): a randomised, double-blind, placebo-controlled phase 3 trial in China[J]. Lancet, 2024,404(10463):1668-1676.
[5] Chen Y, Huang B, Zheng J, et al. Prediction study of prognostic nutrition index on the quality of life of patients with cervical cancer undergoing radiotherapy and chemotherapy[J]. PeerJ, 2023,11:e15442.
[6] Kim J Y, Lee D W, Kim M J, et al. Secondhand smoke exposure, diabetes, and high BMI are risk factors for uterine cervical cancer: a cross-sectional study from the Korea national health and nutrition examination survey (2010-2018)[J]. BMC Cancer, 2021,21(1):880.
[7] Lee S M, Seol A, Cho H W, et al. Optimal Dietary Intake of Riboflavin Associated with Lower Risk of Cervical Cancer in Korea: Korean National Health and Nutrition Examination Survey 2010-2021[J]. Life (Basel), 2024,14(4).
[8] Xu L, Tan Y, Xiang P, et al. Diet-Related Risk Factors for Cervical Cancer: Data from National Health and Nutrition Examination Survey 1999-2018[J]. Nutr Cancer, 2023,75(10):1892-1899.
[9] Lee S M, Shin D, Seol A, et al. Diabetes Is Positively Associated With High Risk of Depression in Korean Cervical Cancer Patients: Korean National Health and Nutrition Examination Survey 2010-2021[J]. Psychiatry Investig, 2025,22(1):57-65.
[10] Horovitz O. Nutritional Psychology: Review the Interplay Between Nutrition and Mental Health[J]. Nutr Rev, 2025,83(3):562-576.
[11] Riess C, Heimann Y, Schleussner E, et al. Disease Perception and Mental Health in Pregnancies with Gestational Diabetes-PsychDiab Pilot Study[J]. J Clin Med, 2023,12(10).
[12] Guo C, Zhan B, Li M Y, et al. Association between oral contraceptives and cervical cancer: A retrospective case-control study based on the National Health and Nutrition Examination Survey[J]. Front Pharmacol, 2024,15:1400667.
[13] Lee E A, Shin J, Hwang E J, et al. Breast and Cervical Cancer Screening Behavior in Female Cancer Survivors: The Korea National Health and Nutrition Examination Survey, 2007-2012[J]. Korean J Fam Med, 2017,38(3):116-121.
[14] 中国抗癌协会妇科肿瘤专业委员会. 子宫颈癌诊断与治疗指南(2021年版)[J]. 中国癌症杂志, 2021,31(6):474-489.
[15] 李贤, 刘桂芬, 何大卫, 等. 重复测量设计样本含量估计[J]. 中国卫生统计, 2001,18(4):204-206.
[16] Broadbent E, Petrie K J, Main J, et al. The brief illness perception questionnaire[J]. J Psychosom Res, 2006,60(6):631-637.
[17] 梅雅琪, 李惠萍, 杨娅娟, 等. 中文版疾病感知问卷简化版在女性乳腺癌患者中的信效度检验[J]. 护理学报, 2015(24):11-14.
[18] 汤丹丹, 温忠麟. 共同方法偏差检验:问题与建议[J]. 心理科学, 2020,43(01):215-223.
[19] Mishra A, Giuliani G, Longo V D. Nutrition and dietary restrictions in cancer prevention[J]. Biochim Biophys Acta Rev Cancer, 2024,1879(1):189063.
[20] Ahmedah H T, Basheer H A, Almazari I, et al. Introduction to Nutrition and Cancer[J]. Cancer Treat Res, 2024,191:1-32.
[21] Wiseman M J. Nutrition and cancer: prevention and survival[J]. Br J Nutr, 2019,122(5):481-487.
[22] Martinez-Garay C, Djouder N. Dietary interventions and precision nutrition in cancer therapy[J]. Trends Mol Med, 2023,29(7):489-511.
[23] Luo Y, Zhang L, Mao D, et al. Symptom clusters and impact on quality of life in lung cancer patients undergoing chemotherapy[J]. Qual Life Res, 2024,33(12):3363-3375.
[24] Koshimoto S, Yamazaki T, Amano K, et al. Psychosocial Factors and the Need for Multidisciplinary Support in Nutrition Counselling for Cancer Chemotherapy Patients[J]. Nutrients, 2023,15(12).
[25] Tripodi S I, Bergami E, Panigari A, et al. The role of nutrition in children with cancer[J]. Tumori, 2023,109(1):19-27.
[26] Barreira J V. The Role of Nutrition in Cancer Patients[J]. Nutr Cancer, 2021,73(11-12):2849-2850.
[27] Contaldo F, Santarpia L, Cioffi I, et al. Nutrition Transition and Cancer[J]. Nutrients, 2020,12(3).
[28] Zitvogel L, Pietrocola F, Kroemer G. Nutrition, inflammation and cancer[J]. Nat Immunol, 2017,18(8):843-850.
[29] Miao J, Wang L, Ong E, et al. Effects of induction chemotherapy on nutrition status in locally advanced nasopharyngeal carcinoma: a multicentre prospective study[J]. J Cachexia Sarcopenia Muscle, 2023,14(2):815-825.
[30] Anderson P M. Editorial of Special Issue "Diet and Nutrition during Chemotherapy and Radiotherapy"[J]. Nutrients, 2022,14(12).
[31] Puklin L S, Ferrucci L M, Harrigan M, et al. Improving lifestyle behaviors during chemotherapy for breast cancer: The Lifestyle, Exercise, and Nutrition Early After Diagnosis (LEANer) Trial[J]. Cancer, 2024,130(14):2440-2452.
[32] Hamdan M H, Badrasawi M M, Abu A R. Nutrition and functional status among Palestinian cancer patients receiving chemotherapy[J]. J Taibah Univ Med Sci, 2022,17(2):264-270.
[33] Flores-Perez J A, de la Rosa O F, Argenes Y, et al. Nutrition, Cancer and Personalized Medicine[J]. Adv Exp Med Biol, 2019,1168:157-168.
[34] Puklin L S, Irwin M L, Sanft T, et al. Barriers to and facilitators of improving physical activity and nutrition behaviors during chemotherapy for breast cancer: a sequential mixed methods study[J]. Support Care Cancer, 2024,32(9):590.
[35] Momokita M, Abe A, Shibata K, et al. Association between oral function and nutrition in gastric cancer patients undergoing chemotherapy[J]. Oral Dis, 2023,29(8):3157-3163.
PDF(1195 KB)

Accesses

Citation

Detail

Sections
Recommended

/

〈 〉